LCZ696
Showing 1 - 25 of 66
Heart Failure, Essential Hypertension Trial in Moscow (LCZ 696, Valsartan)
Recruiting
- Heart Failure
- Essential Hypertension
- LCZ 696
- Valsartan
-
Moscow, Russian FederationNational Medical Research Center for Cardiology
Jan 10, 2022
Heart Failure Trial in New Haven (LCZ 696, Placebo, Para-aminohippurate)
Recruiting
- Heart Failure
- LCZ 696
- +4 more
-
New Haven, ConnecticutYale New Haven Hospital
Dec 27, 2022
Covid19 Trial in Durham (Sacubitril / Valsartan Oral Tablet [Entresto], Placebo)
Recruiting
- Covid19
- Sacubitril / Valsartan Oral Tablet [Entresto]
- Placebo
-
Durham, North CarolinaDuke University Medical Center
Jun 24, 2022
Diabetes, Type 2, Diastolic Dysfunction Trial in Rochester (LCZ 696, Placebos)
Recruiting
- Diabetes Mellitus, Type 2
- Diastolic Dysfunction
- LCZ 696
- Placebos
-
Rochester, MinnesotaMayo Clinic in Rochester
Oct 12, 2021
Heart Failure With Preserved Ejection Fraction (HFpEF) Trial in Japan (LCZ696)
Terminated
- Heart Failure With Preserved Ejection Fraction (HFpEF)
- LCZ696
-
Seto-city, Aichi, Japan
- +16 more
Oct 7, 2021
Chronic Heart Failure With Reduced Ejection Fraction Trial in Germany (LCZ696, Enalapril, Placebo matching enalapril)
Completed
- Chronic Heart Failure With Reduced Ejection Fraction
- LCZ696
- +3 more
-
Regensburg, Bavaria, Germany
- +33 more
Oct 7, 2021
Hypertension Trial in Germany, Switzerland, United Kingdom (sacubitril/valsartan (LCZ696), olmesartan, to sacubitril/valsartan
Completed
- Hypertension
- sacubitril/valsartan (LCZ696)
- +4 more
-
Berlin, Germany
- +3 more
Dec 9, 2020
Hypertension Trial in Lanzhou (Sacubitril/Valsartan, Valsartan)
Recruiting
- Hypertension
-
Lanzhou, GuSu, ChinaDepartment of Cardiology, Second Hospital of Lanzhou University
Mar 12, 2021
Heart Failure Trial in Moscow (LCZ696)
Completed
- Heart Failure
- LCZ696
-
Moscow, Russian FederationGOUVPO Russian Peoples´ Friendship University, Center of Applied
Dec 16, 2020
Chronic Heart Failure, Sleep Apnea Syndrome Trial in France (SACUBITRIL - VALSARTAN (formerly LCZ696, ENTRESTO®))
Completed
- Chronic Heart Failure
- Sleep Apnea Syndrome
- SACUBITRIL - VALSARTAN (formerly LCZ696, ENTRESTO®)
-
Bordeaux, Pessac, France
- +5 more
Jun 10, 2021
Heart Failure, Exercise Tolerance, Vasodilation Trial in São Paulo (Neprilysin, Enalapril)
Completed
- Heart Failure
- +4 more
-
São Paulo, SP, BrazilMarcelo Rodrigues dos Santos
Oct 21, 2020
Heart Failure, Reduced Ejection Fraction Trial in United States (sacubitril/valsartan (LCZ696), enalapril, matching
Completed
- Heart Failure, Reduced Ejection Fraction
- sacubitril/valsartan (LCZ696)
- +3 more
-
Fort Payne, Alabama
- +22 more
Oct 6, 2021
Atrial Remodeling, Myocardial Dysfunction, Left Ventricular Remodeling Trial in Dun Laoghaire, Dublin (Sacubitril-Valsartan,
Active, not recruiting
- Atrial Remodeling
- +8 more
-
Dun Laoghaire, Co Dublin, Ireland
- +1 more
May 10, 2021
Six Months Clinical and Echocardiographic Outcome of ARNI LCZ696
Completed
- Heart Failure With Reduced Ejection Fraction
- LCZ 696
-
Cairo, EgyptCairo University
Jan 14, 2020
Hemodialysis Complication, Heart Failure Trial in Guangzhou (Sacubitril / Valsartan Oral Tablet [Entresto], Valsartan 80mg
Unknown status
- Hemodialysis Complication
- Heart Failure
- Sacubitril / Valsartan Oral Tablet [Entresto]
- Valsartan 80mg Tablet
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Oct 4, 2020
Heart Failure Trial in Worldwide (sacubitril/valsartan)
Active, not recruiting
- Heart Failure
-
Loma Linda, California
- +78 more
Nov 18, 2022
Acute Heart Failure Trial in United States (sacubitril/valsartan (LCZ696), Enalapril, sacubitril/valsartan (LCZ696) matching )
Completed
- Acute Heart Failure
- sacubitril/valsartan (LCZ696)
- +3 more
-
Birmingham, Alabama
- +122 more
Dec 9, 2020
Heart Failure Trial in United States (LCZ696 (sacubitril/valsartan))
Completed
- Heart Failure
- LCZ696 (sacubitril/valsartan)
-
Birmingham, Alabama
- +76 more
Oct 6, 2021
Heart Failure and Reduced Ejection Fraction Trial in United States (LCZ696 (sacubitril/valsartan), Enalapril, Placebo of
Completed
- Heart Failure and Reduced Ejection Fraction
- LCZ696 (sacubitril/valsartan)
- +3 more
-
Birmingham, Alabama
- +80 more
Dec 9, 2020
Heart Failure With Reduced Ejection Fraction Trial in Worldwide (LCZ696)
Completed
- Heart Failure With Reduced Ejection Fraction
- LCZ696
-
Quilmes, Buenos Aires, Argentina
- +152 more
Mar 29, 2021
Heart Failure With Preserved Ejection Fraction Trial in Worldwide (sacubitril/valsartan, Enalapril, Valsartan)
Completed
- Heart Failure With Preserved Ejection Fraction
- sacubitril/valsartan
- +5 more
-
Andalusia, Alabama
- +380 more
Oct 7, 2021
Chronic Heart Failure With Reduced Ejection Fraction Trial in Worldwide (LCZ696 (Sacubitril/Valsartan), Placebo of LCZ696
Completed
- Chronic Heart Failure With Reduced Ejection Fraction
- LCZ696 (Sacubitril/Valsartan)
- +3 more
-
Edegem, Antwerpen, Belgium
- +118 more
Sep 1, 2020
Heart Failure With Reduced Ejection Fraction (HF-rEF) Trial in Worldwide (LCZ696)
No longer available
- Heart Failure With Reduced Ejection Fraction (HF-rEF)
- LCZ696
-
Vero Beach, Florida
- +288 more
Feb 10, 2021
Myocardial Infarction, Diastolic Dysfunction Trial in Copenhagen, Odense (Valsartan+ sacubitril, Placebo Oral Tablet)
Recruiting
- Myocardial Infarction
- Diastolic Dysfunction
- Valsartan+ sacubitril
- Placebo Oral Tablet
-
Copenhagen, Denmark
- +1 more
Oct 6, 2021